Secondary Outcomes
Measure: The percentage of subjects who develop symptomatic laboratory-confirmed COVID-19 infection
Time: Through Week 4
Measure: Mortality rate in subjects who develop laboratory-confirmed COVID19
Time: Through Week 8
Measure: Percent of subjects who are hospitalized due to having one or more predefined COVID-19 symptoms and laboratory-confirmed SARS-CoV-2
Time: Through Week 4
Measure: Percent of subjects who require mechanical ventilation, noninvasive ventilation, high flow nasal canula oxygen delivery or ICU admission during the hospitalization for COVID19
Time: Through Week 8
Measure: Safety and tolerability will be assessed by report of AE/SAEs
Time: Through Week 5 and 8